Navinta Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Apothecon- Your trusted partner for APIs & HPAPIs// Emerging leader in therapeutic generic drugs.
One of their notable products is FOSAPREPITANT DIMEGLUMINE, with a corresponding US DMF Number 33105.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 07, 2018, and payment made on September 24, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II